2006
DOI: 10.1016/j.ydbio.2005.10.024
|View full text |Cite
|
Sign up to set email alerts
|

Med-type GATA factors and the evolution of mesendoderm specification in nematodes

Abstract: In the nematode, C. elegans, the divergent GATA-type transcription factors MED-1 and MED-2 are encoded by an unlinked, redundant pair of intronless genes. The med-1,2 genes are among the first to be activated in the embryo and are critical for the specification of the 7-cell stage MS (mesoderm) and E (endoderm) precursor cells. We have previously shown that the binding site recognized by MED-1 is a noncanonical RAGTATAC site that is not expected from the resemblance of its single C4-type zinc finger to those o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
52
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 33 publications
(54 citation statements)
references
References 46 publications
2
52
0
Order By: Relevance
“…Embryos were stained as described (Coroian et al, 2005). For pal-1 staining of med-1,2 and ceh-51; tbx-35 embryos, a mixture of rescued and nonrescued embryos were stained, and the number of mutants was estimated from the array transmission frequency.…”
Section: In Situ Hybridizationmentioning
confidence: 99%
See 1 more Smart Citation
“…Embryos were stained as described (Coroian et al, 2005). For pal-1 staining of med-1,2 and ceh-51; tbx-35 embryos, a mixture of rescued and nonrescued embryos were stained, and the number of mutants was estimated from the array transmission frequency.…”
Section: In Situ Hybridizationmentioning
confidence: 99%
“…In skn-1 mutants, mis-specified MS and E cells adopt the fate of the mesectodermal precursor C (Bowerman et al, 1992). In EMS (the mother of MS and E), SKN-1 activates the zygotic med-1 med-2 (med-1,2) divergent GATA factor gene pair (Coroian et al, 2005;Maduro et al, 2001). Loss of med-1,2 has a similar effect on MS specification as loss of skn-1, but a much weaker effect on E specification owing to parallel contributions to endoderm from SKN-1 and other factors (Goszczynski and McGhee, 2005;Maduro et al, 2005a;Maduro et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…1 As reported in detail elsewhere , we had only limited success producing med-type-arrested embryos by either of these two protocols. With the first protocol, we were able to produce fewer than one gut-granule-negative embryo for every two injected hermaphrodites, which is only marginally higher than that produced by injection of nonspecific control RNA (see also Coroian et al 2006). In our hands, the second protocol produces either sterile mothers or embryos that arrest prior to the stage where they would ordinarily express gut granules.…”
mentioning
confidence: 85%
“…In the first protocol, embryos were collected 7-9 hr following injection of concentrated doublestranded RNA (dsRNA) into the maternal gonad; the rationale for such an early and limited observation period was to more effectively target the transient expression of the med-1/2 genes in the early embryo (Maduro et al 2001;Coroian et al 2006). In the more standard protocol, the RNAi effect is found to be maximally effective from 1 to 3 days following injection (Fire et al 1998;Zipperlen et al 2001;Goszczynski and McGhee 2005;Ahringer 2006); however, these more usual methods of administering RNAi show no effect with the med-1/2 genes (Kamath et al 2003;Goszczynski and McGhee 2005;Sonnichsen et al 2005).…”
mentioning
confidence: 99%
See 1 more Smart Citation